Clinical Trial Update: Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial assessing carfilzomib in combination with bendamustine and dexamethasone for refractory or relapsed multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bendamustine (Bendamustine)
• Carfilzomib (carfilzomib)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Stichting European Myeloma Network | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED